ASH 2021

American Society of Hematology Annual Meeting

Interviews and expert commentary from ASH 2021 — study authors and key opinion leaders discuss the findings and their clinical implications.

ASH 2021 logo
Progression to Acute Myeloid Leukemia Explained by Multi Omics Analysis
Audio Journal of Oncology

Progression to Acute Myeloid Leukemia Explained by Multi Omics Analysis

ATLANTA, USA—A new research method has elucidated cellular processes (involving mutated TP53 oncogene) that can convert a relatively benign myeloproliferative neoplasm into acute myeloid leukemia. Fin

10 October 2022
20:54